916. Febantel, fenbendazole, and oxfendazole (WHO Food Additives Series 41) (1998)

Government Record · Joint FAO/WHO Expert Committee on Food Additives (JECFA); first draft prepared by Dr R. Fuchs · 1998

Joint FAO/WHO Expert Committee on Food Additives (JECFA), 1998: JECFA addendum setting a group ADI of 0-7 micrograms/kg body weight for febantel, fenbendazole and oxfendazole, with the teratogenicity of oxfendazole in sheep as the sensitive endpoint. It also reports a rabbit developmental toxicity study in which oxfendazole caused malformations and resorptions at 100 and 200 mg/kg/day.

The Committee noted that this ADI provides a safety factor of 1000 for teratogenic effects in sheep, which was considered at the thirty-eighth meeting to be the most sensitive species for the teratogenic effects of oxfendazole.

Joint FAO/WHO Expert Committee on Food Additives (JECFA), 1998: JECFA addendum setting a group ADI of 0-7 micrograms/kg body weight for febantel, fenbendazole and oxfendazole, with the teratogenicity of oxfendazole in sheep as the sensitive endpoint. It also reports a rabbit developmental toxicity study in which oxfendazole caused malformations and resorptions at 100 and 200 mg/kg/day. Regulatory evaluation (50th JECFA meeting, Geneva, 1998). Species: rabbits (groups of 20 does, oxfendazole 0, 10, 30, 45 mg/kg/day on gestation days 7-19 in the definitive study; 100-1000 mg/kg/day in the dose-ranging phase), rats (tumour promotion), sheep (teratogenicity referenced from the 38th meeting). No human data. Funder: WHO/FAO; the rabbit study was submitted to WHO by Hoechst Roussel Vet, Wiesbaden. Declared conflicts: none stated. Comparator: untreated controls. The ADI is a residue-intake limit for food, not a human therapeutic dose, and the report does not propose one. Study type: regulatory record.